Skip to main content

Asthma: Steroid Drugs

Question for Department of Health and Social Care

UIN 15262, tabled on 9 June 2022

To ask the Secretary of State for Health and Social Care, how many and what proportion patients with asthma who require three or more courses of oral corticosteroid each year do not receive care from a specialist asthma service.

Answered on

17 June 2022

No specific estimate has been made. NHS England and NHS Improvement’s Severe Asthma Collaborative is developing the capacity of the severe asthma centres to streamline patient pathways to biologic therapy and reduce variation in prescribing and patient management, with a toolkit produced to support clinical teams. The Accelerated Access Collaborative is supporting the increased uptake of biologic therapy through the improved identification of patients with potential severe asthma in primary and secondary care and enable patient referrals to severe asthma centres to determine eligibility.

The information requested on the number and proportion of patients with asthma who require three or more courses of oral corticosteroid each year do not receive care from a specialist asthma service is not held centrally.